Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(600976)"Jianmin Pharmaceutical Group Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600976 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- (600976)"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- Announcement on Approval for Marketing of Crisaborole Ointment
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical